Pioneer of Crystallography Dies

Isabella Karle has passed away at age 95.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Jerome and Isabella Karle received the Department of the Navy Distinguished Civilian Service Awards upon their retirement from the Naval Research Laboratory in 2009.WIKIMEDIA, JOHN F. WILLIAMSIsabella Lugoski Karle, a pioneering chemist who with her husband helped develop a groundbreaking and still-popular method for visualizing the structure of molecules, died earlier this month (October 3) in Arlington, Virginia. She was 95.

Karle’s husband, Jerome Karle, who passed in 2013 at age 94, had developed the technique of X-ray crystallography in the 1950s. This is based on analyzing the patterns of light that bounce off a crystallized molecule. It remains the most widely used method for determining the three-dimensional structure of molecules.

Jerome Karle received the Nobel Prize in Chemistry along with Herbert Hauptman in 1985. Isabella Karle played a big role in his work by demonstrating how the technique could be used.

She had used it to explore the structures of biological molecules found in drugs, steroids, and frog toxins. Karle told The New York Times in 2013, “After I found some structures that no one could have dreamt of solving before, it started to get ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies